nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—ANXA4—liver cancer	0.129	0.143	CbGpPWpGaD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—ANXA5—liver cancer	0.0741	0.0822	CbGpPWpGaD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—ANXA2—liver cancer	0.0678	0.0751	CbGpPWpGaD
Sulfisoxazole—EDNRA—EGFR-dependent Endothelin signaling events—MTOR—liver cancer	0.0394	0.0437	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—NAT2—liver cancer	0.0258	0.263	CrCbGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—CCR4—liver cancer	0.0249	0.0277	CbGpPWpGaD
Sulfisoxazole—EDNRA—EGFR-dependent Endothelin signaling events—HRAS—liver cancer	0.0222	0.0247	CbGpPWpGaD
Sulfisoxazole—Dapsone—NAT2—liver cancer	0.0202	0.206	CrCbGaD
Sulfisoxazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—liver cancer	0.0198	0.022	CbGpPWpGaD
Sulfisoxazole—CYP2C9—CYP2E1 reactions—CYP2E1—liver cancer	0.0168	0.0186	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—PRKCE—liver cancer	0.0163	0.0181	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—liver cancer	0.0155	0.0172	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—RAF1—liver cancer	0.0143	0.0158	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—liver cancer	0.0141	0.0157	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.0129	0.0143	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.0125	0.0138	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—TRIO—liver cancer	0.0124	0.0137	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.0123	0.0136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCR4—liver cancer	0.0117	0.013	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—MAPK14—liver cancer	0.0117	0.013	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.0115	0.0127	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TRIO—liver cancer	0.0111	0.0123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP2E1—liver cancer	0.0104	0.0115	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Tamoxifen metabolism—CYP2E1—liver cancer	0.00999	0.0111	CbGpPWpGaD
Sulfisoxazole—Sulfamethazine—ALB—liver cancer	0.0096	0.0976	CrCbGaD
Sulfisoxazole—Sulfadiazine—CYP2E1—liver cancer	0.0096	0.0976	CrCbGaD
Sulfisoxazole—Sulfamerazine—ALB—liver cancer	0.00938	0.0954	CrCbGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00918	0.0102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—RAF1—liver cancer	0.00851	0.00944	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00792	0.00878	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.00787	0.00872	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP1A1—liver cancer	0.00746	0.00828	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—JUN—liver cancer	0.00743	0.00824	CbGpPWpGaD
Sulfisoxazole—Sulfamethizole—ALB—liver cancer	0.00727	0.074	CrCbGaD
Sulfisoxazole—CYP2C9—Tamoxifen metabolism—CYP1A1—liver cancer	0.00718	0.00796	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—MAPK8—liver cancer	0.00703	0.00779	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—PRKCE—liver cancer	0.00684	0.00758	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00679	0.00753	CbGpPWpGaD
Sulfisoxazole—Sulfanilamide—CYP2E1—liver cancer	0.00652	0.0663	CrCbGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00642	0.00712	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—HPGDS—liver cancer	0.00612	0.00679	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCE—liver cancer	0.00612	0.00678	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCR4—liver cancer	0.00599	0.00664	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—UGDH—liver cancer	0.00584	0.00647	CbGpPWpGaD
Sulfisoxazole—Dapsone—CYP2E1—liver cancer	0.00581	0.0591	CrCbGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—F2—liver cancer	0.00475	0.00527	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—HRAS—liver cancer	0.00469	0.0052	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—F2—liver cancer	0.00469	0.0052	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—GGT1—liver cancer	0.00458	0.00508	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CHN2—liver cancer	0.00456	0.00506	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00446	0.00495	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00431	0.00478	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00426	0.00472	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.00425	0.00471	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IFT88—liver cancer	0.00417	0.00463	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—AKT1—liver cancer	0.00414	0.00459	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—ALB—liver cancer	0.00408	0.0415	CrCbGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00369	0.00409	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00358	0.00398	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—TRIO—liver cancer	0.00353	0.00392	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.0035	0.00388	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—NR1H4—liver cancer	0.00341	0.00378	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR4—liver cancer	0.00339	0.00375	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTA3—liver cancer	0.00335	0.00372	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTA3—liver cancer	0.00331	0.00367	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—TRIO—liver cancer	0.00321	0.00356	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.00319	0.00354	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00314	0.00349	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.0031	0.00344	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR4—liver cancer	0.00307	0.00341	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTA4—liver cancer	0.00307	0.0034	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00306	0.00339	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTA4—liver cancer	0.00302	0.00335	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTA2—liver cancer	0.00299	0.00331	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTA1—liver cancer	0.00288	0.0032	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—NAT2—liver cancer	0.00285	0.00316	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—NAT2—liver cancer	0.00281	0.00312	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SHC3—liver cancer	0.00256	0.00284	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00251	0.00279	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—F2—liver cancer	0.00239	0.00266	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	0.00239	0.00265	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—HPGDS—liver cancer	0.00228	0.00253	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—PIK3CA—liver cancer	0.00212	0.00235	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00211	0.00234	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.00207	0.00229	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FST—liver cancer	0.00199	0.0022	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PRKCE—liver cancer	0.00195	0.00216	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.0019	0.00211	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TRIO—liver cancer	0.00189	0.0021	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2E1—liver cancer	0.00186	0.00206	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	0.00183	0.00203	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR4—liver cancer	0.00182	0.00201	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PRKCE—liver cancer	0.00177	0.00196	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.00176	0.00195	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CSF2—liver cancer	0.00172	0.00191	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GGT1—liver cancer	0.00171	0.00189	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.00168	0.00186	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CSF2—liver cancer	0.00157	0.00174	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.00153	0.0017	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.00151	0.00168	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADAM17—liver cancer	0.00144	0.00159	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.00141	0.00156	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.00139	0.00154	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00136	0.00151	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—F2—liver cancer	0.00135	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PSMD10—liver cancer	0.00135	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PSMA4—liver cancer	0.00135	0.0015	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.00133	0.00148	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.00132	0.00146	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00131	0.00145	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CG—liver cancer	0.00129	0.00144	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—F2—liver cancer	0.00123	0.00136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CG—liver cancer	0.00118	0.0013	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CD—liver cancer	0.00114	0.00126	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCE—liver cancer	0.00105	0.00116	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CD—liver cancer	0.00103	0.00115	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.001	0.00111	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UGDH—liver cancer	0.000998	0.00111	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CB—liver cancer	0.000992	0.0011	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF2—liver cancer	0.000991	0.0011	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—EPT1—liver cancer	0.000938	0.00104	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CSF2—liver cancer	0.000925	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RAF1—liver cancer	0.000923	0.00102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—H2AFX—liver cancer	0.000912	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—liver cancer	0.000911	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CB—liver cancer	0.000901	0.000999	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TAT—liver cancer	0.000889	0.000986	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000875	0.00097	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—liver cancer	0.000827	0.000918	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TERT—liver cancer	0.000824	0.000914	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KDR—liver cancer	0.000754	0.000836	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK14—liver cancer	0.000749	0.000831	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ESR1—liver cancer	0.000735	0.000815	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—F2—liver cancer	0.000726	0.000805	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CG—liver cancer	0.000695	0.00077	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APC—liver cancer	0.000695	0.00077	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000655	0.000726	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BRAF—liver cancer	0.000653	0.000724	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CD—liver cancer	0.000611	0.000677	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CA—liver cancer	0.000605	0.000671	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CPT1B—liver cancer	0.000605	0.000671	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GLUL—liver cancer	0.000605	0.000671	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SERPINE1—liver cancer	0.000604	0.00067	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KRAS—liver cancer	0.000598	0.000663	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NR1H4—liver cancer	0.000583	0.000647	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA3—liver cancer	0.000573	0.000636	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CA—liver cancer	0.000549	0.000609	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RAF1—liver cancer	0.000545	0.000605	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MTOR—liver cancer	0.000532	0.00059	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CB—liver cancer	0.000532	0.00059	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA4—liver cancer	0.000524	0.000581	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000512	0.000568	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA2—liver cancer	0.000511	0.000567	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HRAS—liver cancer	0.000508	0.000564	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1B—liver cancer	0.0005	0.000554	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—liver cancer	0.000494	0.000548	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA1—liver cancer	0.000493	0.000547	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—liver cancer	0.00049	0.000543	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—liver cancer	0.000489	0.000542	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NAT2—liver cancer	0.000487	0.00054	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—liver cancer	0.000486	0.000539	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCND1—liver cancer	0.000477	0.000528	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JUN—liver cancer	0.000476	0.000527	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CTNNB1—liver cancer	0.000472	0.000523	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000469	0.00052	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDOB—liver cancer	0.000467	0.000518	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP9—liver cancer	0.000463	0.000513	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1A—liver cancer	0.000461	0.000511	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK8—liver cancer	0.00045	0.000499	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—liver cancer	0.000449	0.000498	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CRABP1—liver cancer	0.000446	0.000494	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—liver cancer	0.000415	0.000461	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT3—liver cancer	0.000411	0.000456	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000401	0.000445	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HPGDS—liver cancer	0.00039	0.000432	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000387	0.00043	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MYC—liver cancer	0.000382	0.000424	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFB1—liver cancer	0.000381	0.000423	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KRAS—liver cancer	0.000353	0.000392	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000353	0.000391	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000348	0.000386	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PSMA4—liver cancer	0.000347	0.000385	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PSMD10—liver cancer	0.000347	0.000385	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GOT2—liver cancer	0.000338	0.000375	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CA—liver cancer	0.000324	0.00036	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2E1—liver cancer	0.000318	0.000352	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—liver cancer	0.000314	0.000348	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000308	0.000341	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HRAS—liver cancer	0.0003	0.000333	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYCS—liver cancer	0.000297	0.00033	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GGT1—liver cancer	0.000292	0.000323	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GOT1—liver cancer	0.000292	0.000323	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—liver cancer	0.000287	0.000319	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—liver cancer	0.000265	0.000294	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—liver cancer	0.000262	0.00029	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMOX1—liver cancer	0.000258	0.000286	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM1—liver cancer	0.000241	0.000267	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1A1—liver cancer	0.000228	0.000253	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTHFR—liver cancer	0.000213	0.000236	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARA—liver cancer	0.000209	0.000231	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000187	0.000208	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CG—liver cancer	0.000179	0.000198	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARG—liver cancer	0.000172	0.000191	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CD—liver cancer	0.000157	0.000174	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—liver cancer	0.000155	0.000172	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CB—liver cancer	0.000137	0.000152	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CA—liver cancer	8.35e-05	9.26e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—liver cancer	6.82e-05	7.56e-05	CbGpPWpGaD
